Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 50 for “"NONMEM"”.
-
Evaluation of bootstrapping as a validation technique for population pharmacokinetic models
… validation method was executed using NONMEM for model estimation and the resulting statistics were used to detect models developed from influence data. The metrics of choice were mean absolute prediction error (MAPE) and mean squared prediction error (MSPE). In phase IV, the impact of …
-
Application of pharmacometrics for covariate selection and dose optimization of tacrolimus in adult kidney transplant recipients
… non-linear mixed effects modeling approach in NONMEM®. The troughs were characterized by a steady state infusion model. Covariates were analyzed using a forward selection (p<0.0.1) backward elimination (p<0.001) approach. We formulated an equation that predicts the CL/F of an individual based …
-
Clinical applications of machine learning methods on pharmaceutical development
… is modeled by Nonlinear Mixed Effects Modeling (NONMEM), and the various simulated intensive datasets are conducted for machine learning experiments. Reinforcement Learning (RL) is presented as a successful practice to facilitate the optimal dose selection while providing promising accuracy in …
-
Pharmacometric modeling of anti-cancer agents: application to gemcitabine, PQIP and irinotecan.
… mixed-effects modeling using FOCE-I method in NONMEM. The analysis showed that cranial radiation delivered during irinotecan administration enhances uptake in to CSF. The second aim of dissertation was to quantitatively evaluate the drug administration sequence effects of insulin-like growth …
-
Clinical pharmacokinetics of tacrolimus in Asian liver transplant patients
… and population parameter estimates using the NONMEM program. This can be achieved by (A) determining the population PK of Tac in the local Asian paediatric liver transplant recipients, which represents a special subpopulation with special PK characteristics, and (B) determining the population …
-
Investigation of Change in EEG Photoparoxysmal Response as a marker of Anti-Epilepsy Drug Efficacy: Modelled in Juvenile Myoclonic Epilepsy with Sodium Valproate and Lamotrigine.
… confidence intervals overlapped placebo. Pk-Pd NONMEM analysis of the same data demonstrated good correlation with LTG effect but no effect on the PPR or SPR for single doses of VPA. Concern about stability of the SPR as a test parameter across the waking day led us to analyse 2058 PPR “placebo …
-
Efficient Parameter Estimation in Preclinical Animal Pharmacokinetic Studies
… data obtained by "destructive sampling". The NONMEM approach does, however, provide estimates of both average values of pharmacokinetic parameters and their statistical distribution within the population. In this thesis data were generated by simulation (assuming no covariance), and analysed …
-
Pharmacokinetics, pharmacodynamics, and dose optimization of fludarabine in nonmyeloablative hematopoietic stem cell transplantation.
… pharmacokinetic models were built using NONMEM. Covariate models for pharmacokinetic parameters were derived, including a model for the typical value of clearance in the population as a function of weight, creatinine clearance, and comorbidity score. Bayesian generalized linear models …
-
Population pharmacokinetics and Bayesian forecasting of vancomycin in neonates requiring intensive care
… a nonlinear mixed effects modeling program (NONMEM). Significant covariates were those that resulted in a decrease in the minimum value of the objective function (MOF) of > 6.6 points. Final one- and twocompartment models were evaluated with data from a naive cohort of 65 patients. Following …
-
Application of an active comparator-based benefit-risk Assessment in evaluating clinical trial design features of a new chemical entity using a Bayesian decision-theoretic framework.
… developed as hierarchical nonlinear model using NONMEM® and WinBUGS®. A Sensitivity analysis is performed to test the robustness of the selected dose with varying decision attributes.
-
Population Pharmacokinetics of Therapeutic Monoclonal Antibodies: Examples and Estimation Method Performance Differences
… mixed effects modeling and the software NONMEM. A total of 912 cetuximab concentrations were available from 143 patients with recurrent and/or metastatic SCCHN enrolled in two phase I/II studies. The PK of cetuximab was best described by a two-compartment model with Michaelis-Menten type …
-
Development of novel methods in population pharmacokinetics using machine learning and fractional differential equations
… of such methods to the widely used NONMEM software that performs non-linear mixed effects modeling in the context of pharmacometrics. Chapter 1We address the problem of model misspecification in population pharmacokinetics(PopPK), by modeling residual unexplained variability (RUV) by …
-
Φαρμακοκινητική μελέτη της δοριπενέμης στο εγκεφαλονωτιαίο υγρό νευρολογικών ασθενών με μη-φλεγμαίνουσες μήνιγγες
… της στο εγκεφαλονωτιαίο υγρό (ΕΝΥ) με τη βοήθεια NONMEM 7.2 πληθυσμιακού φαρμακοκινητικού μοντέλου. Ασθενείς και μέθοδος: 38 νευρολογικοί ασθενείς χωρίς ενεργή λοίμωξη του ΚΝΣ και με άθικτο ΑΕΦ έλαβαν εφάπαξ δόση δοριπενέμης 500mg ως χημειοπροφύλαξη πρίν τη χειρουργική εμφύτευση ενδορραχιαίας …
-
Pharmacokinetic modeling of vancomycin in children, pre-adolescent, and adolescent patients : development, assessment, and application
… performed via non linear mixed effects modeling (NONMEM) in 2 phases. In phase I, a vancomycin population pharmacokinetic model was developed based on data from 200 children (aged 2-17 years) using a two-compartment model. Variables tested for inclusion in the model were serum creatinine (SCR), …
-
Modelo farmacocinético populacional do metotrexato para pacientes pediátricos do Hospital de Clínicas de Porto Alegre com leucemia linfoblástica aguda
… O modelo foi desenvolvido utilizando o software NONMEM 7.4 (Icon®), subrotinas ADVAN3 TRANS4 e o método de estimativa FOCE-I. Para explicar a variabilidade interindividual, avaliamos covariáveis a partir de dados demográficos, dados bioquímicos e informações genéticas de polimorfismo de …
-
Diagnostics for nonlinear models with application to population pharmacokinetic modeling
… software exists for pharmacokinetic modeling: NONMEM, Monolix. General modeling software, such as PROC NLMIX in SAS and the package nlme in S/R, can also be used. A common problem is that these tools lack adequate diagnostic tools to assess the model fit. The Federal Drug Administration is …
-
Intranasal and rectal diazepam for rescue therapy: assessment of pharmacokinetics and tolerability.
… administration using both model-based analysis (NONMEM) and graphical methods. The primary finding from this work was that, only the microemulsion-based formulations, particularly Nas-B could be used for further development as the glycofurol formulation was not well tolerated by subjects. The …
-
D-optimal design of a pediatric pharmacokinetic study of a fixed dose combination product of rifampicin-pyrazinamide-isoniazid for the treatment of tuberculosis
… μέσω προσομοιώσεων και εκτιμήσεων στο πακέτο NONMEM. Bootstrap, Visual predictive check plots και γραφήματα καλής προσαρμογής δημιουργήθηκαν. Τελικά σχεδιάστηκε, μια φαρμακοκινητική μελέτη με 4 δείγματα αίματος ανά ασθενή. Οι βέλτιστοι χρόνοι δειγματοληψίας για την πρώτη κοορτή είναι στις 0.10 …
-
Modelo farmacocinético populacional do tacrolimo em pacientes transplantados de medula óssea em um hospital universitário de Porto Alegre
… farmacocinética populacional nos softwares NONMEM (versão 7.4) e PsN versão 4.9.0, com o método de estimativa condicional de primeira ordem com interações (FOCE-I). O modelo foi selecionado a partir do valor mínimo da função objetiva (OFV) e avaliado por meio da validação interna e externa, …
-
Ανάλυση πληθυσμιακής φαρμακοκινητικής της τεϊκοπλανίνης σε νεογνά με ενδονοσοκομειακές λοιμώξεις
… PK (popPK) analysis was performed using NONMEM software. Monte-Carlo (MC) simulations were performed to evaluate currently recommended dosing based on a pharmacodynamic index of area under the concentration-time curve (AUC)/MIC ratio of ≥ 400. A two compartment model with linear …
Page 1 of 3